Sofia A Omari (Sofia Omari)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Acute Lymphoblastic Leukemia

Drug Administration

Top Venues

Science translational medicine

Medical oncology (Northwood, London, England)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ernest Moles, Christopher B Howard, Pie Huda, Mawar Karsa, Hannah McCalmont, Kathleen Kimpton, Alastair Duly, Yongjuan Chen, Yizhou Huang, Melinda L Tursky, David Ma, Sonia Bustamante, Russell Pickford, Patrick Connerty, Sofia A Omari, Christopher J Jolly, Swapna Joshi, Sylvie Shen, John E Pimanda, Alla Dolnikov, Laurence C Cheung, Rishi Sury Kotecha, Murray D Norris, Michelle Haber, Charles E de Bock, Klaartje Somers, Richard B Lock, Kristofer J Thurecht, Maria Kavallaris
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. Science translational medicine 15 (696) (2023)
Ernest Moles, Christopher B Howard, Pie Huda, Mawar Karsa, Hannah McCalmont, Kathleen Kimpton, Alastair Duly, Yongjuan Chen, Yizhou Huang, Melinda L Tursky, David Ma, Sonia Bustamante, Russell Pickford, Patrick Connerty, Sofia A Omari, Christopher J Jolly, Swapna Joshi, Sylvie Shen, John E Pimanda, Alla Dolnikov, Laurence C Cheung, Rishi Sury Kotecha, Murray D Norris, Michelle Haber, Charles E de Bock, Klaartje Somers, Richard B Lock, Kristofer J Thurecht, Maria Kavallaris
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. Science translational medicine 15 (696) (2023)
Sofia A Omari, Dominic P Geraghty, Alhossain A Khalafallah, Pooja Venkat, Yvette M Shegog, Scott J Ragg, Charles E de Bock, Murray J Adams
Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies. Medical oncology (Northwood, London, England) 39 (5) (2022)
Elyse C Page, Susan L Heatley, Laura N Eadie, Barbara J McClure, Charles E de Bock, Sofia A Omari, David T Yeung, Timothy P Hughes, Paul Q Thomas, Deborah L White
HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. Oncogene (2021)
Quentin Van Thillo, Jolien De Bie, Janith A Seneviratne, Sofie Demeyer, Sofia A Omari, Anushree Balachandran, Vicki Zhai, Wai L Tam, Bram Sweron, Ellen Geerdens, Olga Gielen, Sarah Provost, Heidi Segers, Nancy Boeckx, Glenn M Marshall, Belamy B Cheung, Kiyotaka Isobe, Itaru Kato, Junko Takita, Timothy G Amos, Ira W Deveson, Hannah McCalmont, Richard B Lock, Ethan P Oxley, Maximilian M Garwood, Ross A Dickins, Anne Uyttebroeck, Daniel R Carter, Jan Cools, Charles E de Bock
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia. Nature communications 12 (1) (2021)